BRIEF-Globeimmune to delist and deregister common stock from Nasdaq Capital Market

* Globeimmune announces delisting and deregistration of common stock from nasdaq capital market Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.